235 related articles for article (PubMed ID: 31115553)
41. Potential roles of claudin-3 and claudin-4 in ovarian cancer management.
Uthayanan L; El-Bahrawy M
J Egypt Natl Canc Inst; 2022 Jun; 34(1):24. PubMed ID: 35665865
[TBL] [Abstract][Full Text] [Related]
42. Expression of apoptosis signal-regulating kinase 1 is associated with tight junction protein claudin-6 in cervical carcinoma.
Zhang X; Ruan Y; Li Y; Lin D; Liu Z; Quan C
Int J Clin Exp Pathol; 2015; 8(5):5535-41. PubMed ID: 26191261
[TBL] [Abstract][Full Text] [Related]
43. Xenopus oocytes as a heterologous expression system for analysis of tight junction proteins.
Vitzthum C; Stein L; Brunner N; Knittel R; Fallier-Becker P; Amasheh S
FASEB J; 2019 Apr; 33(4):5312-5319. PubMed ID: 30645152
[TBL] [Abstract][Full Text] [Related]
44. Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma.
Gyulai M; Harko T; Fabian K; Karsko L; Agocs L; Szigeti B; Fillinger J; Szallasi Z; Pipek O; Moldvay J
Pathol Oncol Res; 2023; 29():1611328. PubMed ID: 37621953
[No Abstract] [Full Text] [Related]
45. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
Ye J; Li L; Feng P; Wan J; Li J
Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
[TBL] [Abstract][Full Text] [Related]
46. Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma.
Zhang Z; Wang A; Sun B; Zhan Z; Chen K; Wang C
J Cardiothorac Surg; 2013 Apr; 8():95. PubMed ID: 23591077
[TBL] [Abstract][Full Text] [Related]
47. Differential expression of claudin 1, 3, and 4 during normal mammary gland development in the mouse.
Blanchard AA; Watson PH; Shiu RP; Leygue E; Nistor A; Wong P; Myal Y
DNA Cell Biol; 2006 Feb; 25(2):79-86. PubMed ID: 16460231
[TBL] [Abstract][Full Text] [Related]
48. Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer.
Long XB; Sun GB; Hu S; Liang GT; Wang N; Zhang XH; Cao PP; Zhen HT; Cui YH; Liu Z
Oncol Rep; 2009 Nov; 22(5):1189-95. PubMed ID: 19787239
[TBL] [Abstract][Full Text] [Related]
49. The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma.
Starska K; Forma E; Lewy-Trenda I; Stasikowska O; Bryś M; Krajewska WM; Łukomski M
Folia Histochem Cytobiol; 2009 Jan; 47(3):401-10. PubMed ID: 20164024
[TBL] [Abstract][Full Text] [Related]
50. Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1, -8 and -12.
Gröne J; Weber B; Staub E; Heinze M; Klaman I; Pilarsky C; Hermann K; Castanos-Velez E; Röpcke S; Mann B; Rosenthal A; Buhr HJ
Int J Colorectal Dis; 2007 Jun; 22(6):651-9. PubMed ID: 17047970
[TBL] [Abstract][Full Text] [Related]
51. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.
Li YR; Wu JM; Wang L; Huang X; Shi J; Hu LH
Acta Otolaryngol; 2005 Apr; 125(4):409-14. PubMed ID: 15823813
[TBL] [Abstract][Full Text] [Related]
52. [Expression of CLDN1 and Its Nuclear Distribution in Esophageal Squamous Carcinoma].
Zhang DW; Wu J; Ren DL; Li J; Hu Z; Dai TY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 48(6):850-856. PubMed ID: 29260519
[TBL] [Abstract][Full Text] [Related]
53. Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma.
Yoshizawa K; Nozaki S; Kato A; Hirai M; Yanase M; Yoshimoto T; Kimura I; Sugiura S; Okamune A; Kitahara H; Noguchi N; Kato K; Ueki K; Kawashiri S
Oncol Rep; 2013 Feb; 29(2):445-50. PubMed ID: 23229436
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-519a demonstrates significant tumour suppressive activity in laryngeal squamous cells by targeting anti-carcinoma HuR gene.
Shen Z; Zhan G; Deng H; Ren Y; Ye D; Xiao B; Guo J
J Laryngol Otol; 2013 Dec; 127(12):1194-202. PubMed ID: 24300127
[TBL] [Abstract][Full Text] [Related]
55. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
[TBL] [Abstract][Full Text] [Related]
56. Claudin gene expression profiles and clinical value in colorectal tumors classified according to their molecular subtype.
Cherradi S; Martineau P; Gongora C; Del Rio M
Cancer Manag Res; 2019; 11():1337-1348. PubMed ID: 30863148
[TBL] [Abstract][Full Text] [Related]
57. Claudins and Gastric Cancer: An Overview.
Hashimoto I; Oshima T
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053454
[TBL] [Abstract][Full Text] [Related]
58. Claudin-3, claudin-7, and claudin-10 show different distribution patterns during decidualization and trophoblast invasion in mouse and human.
Schumann S; Buck VU; Classen-Linke I; Wennemuth G; Grümmer R
Histochem Cell Biol; 2015 Dec; 144(6):571-85. PubMed ID: 26340953
[TBL] [Abstract][Full Text] [Related]
59. Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival.
Bouchagier KA; Assimakopoulos SF; Karavias DD; Maroulis I; Tzelepi V; Kalofonos H; Karavias DD; Kardamakis D; Scopa CD; Tsamandas AC
In Vivo; 2014; 28(3):315-26. PubMed ID: 24815833
[TBL] [Abstract][Full Text] [Related]
60. The expression and function of epithelial membrane protein 1 in laryngeal carcinoma.
Li H; Zhang X; Jiang X; Ji X
Int J Oncol; 2017 Jan; 50(1):141-148. PubMed ID: 27909719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
